查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1710217

2025年全球药物传输设备市场报告

Drug And Gene Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年药物传输装置市场规模将强劲成长。到 2029 年，这一数字将成长至 9.3 亿美元，复合年增长率为 8.7%。预测期内的增长归因于慢性病患病率的不断上升、对个性化医疗的需求不断增长、对基因治疗的认识和采用不断提高、对非侵入性和微创手术的需求以及直接面向患者的治疗模式的日益普及。预测期内的关键趋势包括生物技术和基因工程的进步、药物传输系统的技术进步、研发投资的增加、新型输送平台的开发以及诊断技术的进步。

基因治疗的日益普及预计将推动未来药物输送设备市场的扩张。基因治疗是一种透过引入、移除或修改患者细胞中的遗传物质来治疗或预防疾病的医学方法。基因治疗的需求不断增长，因为它有可能从根本上解决遗传和慢性疾病，并在传统治疗方法不足的地方带来变革性治疗。药物传递装置在基因治疗中发挥着至关重要的作用，透过确保治疗基因的精确定位和控制释放来提高治疗效果。例如，美国科学资源机构美国国家生物技术资讯中心在2023年11月预测，接受基因治疗的新患者数量将从2020年的16,244人增加到2025年的94,696人。因此，基因治疗的普及正在推动药物输送装置市场的成长。

为了获得竞争优势，药物输送设备市场的主要企业正专注于开发融合人工智慧 (AI) 技术的先进产品。药物传输中的人工智慧技术涉及使用人工智慧技术和演算法来提高输送系统的效率、准确性和有效性。例如，2023 年 12 月，专门从事标靶递送聚合物基奈米颗粒的美国公司 Envoya Inc. 宣布推出一种新的基因治疗递送平台。该平台整合了生物聚合物奈米颗粒和人工智慧，以解决当前基因治疗技术的关键局限性，例如病毒载体和脂质奈米颗粒。目的是克服基因治疗传递系统中现有的有关安全性、有效载荷能力和组织靶向性的挑战。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球药物输送设备 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球药物输送设备市场：成长率分析
  • 全球药物传输设备市场表现：规模与成长，2019-2024
  • 全球药物传输设备市场预测：规模与成长，2024-2029 年，2034 年
  • 药物输送设备的全球总目标市场（TAM）

第六章市场区隔

  • 全球药物传输设备市场（依载体）：2019-2024 年、2024-2029 年、2034 年实际资料及预测
  • 病毒性的
  • 非病毒
  • 全球药物传输设备市场：依方法、效能与预测，2019-2024 年、2024-2029 年、2034 年
  • 现场
  • 体外
  • 全球给药装置市场（依给药途径）：2019-2024 年、2024-2029 年、2034 年表现与预测
  • 口服
  • 吸入
  • 经皮
  • 注射
  • 眼科
  • 鼻腔
  • 话题
  • 全球药物传输设备市场，按病毒类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 腺病毒载体
  • 慢病毒载体
  • 腺结合病毒（AAV）载体
  • 单纯疱疹病毒（HSV）载体
  • 逆转录病毒载体
  • 桿状病毒载体
  • 痘苗病毒载体
  • 仙台病毒载体
  • 全球药物传输设备市场非病毒细分市场，依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 脂质奈米颗粒（LNP）
  • 聚合物奈米粒子
  • 脂质体
  • 树状聚合物
  • 裸露DNA/RNA递送
  • 电穿孔输送系统
  • 基于奈米颗粒的递送系统
  • 聚合物胶束和水凝胶

第七章 区域和国家分析

  • 全球药物传输设备市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球药物输送装置市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 药物输送设备市场：竞争格局
  • 药物输送设备市场：公司简介
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Amgen Inc.
  • Moderna Inc.
  • Biogen Inc.
  • Sarepta Therapeutics Inc.
  • SCIEX
  • Halozyme Therapeutics Inc.
  • ViiV Healthcare Limited
  • Uniqure NV
  • Cytokinetics Inc.
  • Prothena Corporation plc
  • Intellia Therapeutics Inc.
  • Voyager Therapeutics Inc.
  • sfm medical devices GmbH
  • Inovio Pharmaceuticals Inc.
  • GenSight Biologics SA

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年药物输送设备市场：提供新机会的国家
  • 2029年药物输送设备市场：细分市场带来新机会
  • 2029年药物传输设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31796

Drug and gene delivery devices are specialized tools designed to transport pharmaceuticals or genetic material into the body for therapeutic purposes. These devices enable targeted treatment of diseases at the molecular level, enhancing precision and efficacy. They play a vital role in advancing personalized medicine by ensuring controlled release and optimal delivery of therapeutic agents to specific cells or tissues, thereby minimizing side effects and maximizing treatment effectiveness.

The main vector types for drug and gene delivery devices include viral and non-viral vectors. Viral gene delivery involves the use of genetically engineered viruses to introduce therapeutic genes into target cells. These methods can be performed in situ (directly within the body) or ex vivo (outside the body, followed by reintroduction). The routes of administration for these devices include oral, inhalation, transdermal, injectable, ocular, nasal, and topical methods.

The drug and gene delivery devices market research report is one of a series of new reports from The Business Research Company that provides drug and gene delivery devices market statistics, including drug and gene delivery devices industry global market size, regional shares, competitors with a drug and gene delivery devices market share, detailed drug and gene delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug and gene delivery devices industry. This drug and gene delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug and gene delivery devices market size has grown strongly in recent years. It will grow from $0.61 $ billion in 2024 to $0.67 $ billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to healthcare infrastructure development, expansion of personalized gene therapy programs, increasing focus on preventive healthcare, rare and orphan diseases, and increasing public awareness about health and treatment options.

The drug and gene delivery devices market size is expected to see strong growth in the next few years. It will grow to $0.93 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the increasing incidence of chronic diseases, growing demand for personalized medicine, increasing awareness and adoption of gene therapy, demand for non-invasive and minimally invasive procedures, and the growing popularity of direct-to-patient delivery models. Major trends in the forecast period include advancements in biotechnology and genetic engineering, technological advancements in drug delivery systems, increasing investment in research and development, the development of novel delivery platforms, and advancements in diagnostic technologies.

The growing adoption of gene therapy is anticipated to drive the expansion of the drug and gene delivery devices market in the future. Gene therapy is a medical approach that involves introducing, removing, or altering genetic material within a patient's cells to treat or prevent diseases. The increasing demand for gene therapy stems from its potential to address genetic disorders and chronic diseases at their source, providing transformative treatment options where conventional therapies may fall short. Drug and gene delivery devices play a crucial role in gene therapy by ensuring precise targeting and controlled release of therapeutic genes, which enhances the effectiveness of treatments. For example, in November 2023, the National Centre for Biotechnology Information, a US-based scientific resource, projected that the number of new patients receiving gene therapies would rise from 16,244 in 2020 to 94,696 by 2025. Thus, the growing adoption of gene therapy is fueling the growth of the drug and gene delivery devices market.

Leading companies in the drug and gene delivery devices market are concentrating on developing advanced products, including artificial intelligence (AI) technology, to secure a competitive advantage. In drug delivery, AI technology involves using AI techniques and algorithms to enhance the efficiency, precision, and effectiveness of delivery systems. For instance, in December 2023, Envoya Inc., a US-based company specializing in polymer-based nanoparticles for targeted delivery, introduced a new gene therapy drug delivery platform. This platform integrates biopolymer nanoparticles with AI to address key limitations of current gene therapy technologies, such as viral vectors and lipid nanoparticles. The goal is to overcome existing challenges related to safety, payload capacity, and tissue targeting in gene therapy delivery systems.

In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. This acquisition was aimed at enhancing Sandoz's portfolio of respiratory medicines and improving patient access to high-quality, complex therapies. Coalesce Product Development Limited is a UK-based company specializing in medical and drug delivery devices.

Major companies operating in the drug and gene delivery devices market are Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Medtronic plc, Amgen Inc., Moderna Inc., Biogen Inc., Sarepta Therapeutics Inc., SCIEX, Halozyme Therapeutics Inc., ViiV Healthcare Limited, Uniqure NV, Cytokinetics Inc., Prothena Corporation plc, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics

North America was the largest region in the drug and gene delivery devices market in 2023. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug and gene delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug and gene delivery devices market consists of sales of microspheres and microneedles, electroporation devices, bioadhesive systems, and gene therapy vectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug And Gene Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug and gene delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug and gene delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug and gene delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Vector: Viral; Non-viral
  • 2) By Method: In Situ; Ex Vivo
  • 3) By Route Of Administration: Oral; Inhalation; Transdermal; Injectable; Ocular; Nasal; Topical
  • Subsegments:
  • 1) By Viral: Adenovirus Vectors; Lentivirus Vectors; Adeno-Associated Virus (AAV) Vectors; Herpes Simplex Virus (HSV) Vectors; Retrovirus Vectors; Baculovirus Vectors; Vaccinia Virus Vectors; Sendai Virus Vectors
  • 2) By Non-Viral: Lipid Nanoparticles (LNP); Polymeric Nanoparticles; Liposomes; Dendrimers; Naked DNA/RNA Delivery; Electroporation-Based Delivery Systems; Nanoparticle-Based Delivery Systems; Polymer Micelles And Hydrogels.
  • Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; AstraZeneca plc; Medtronic plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug And Gene Delivery Devices Market Characteristics

3. Drug And Gene Delivery Devices Market Trends And Strategies

4. Drug And Gene Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Drug And Gene Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug And Gene Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug And Gene Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Drug And Gene Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug And Gene Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug And Gene Delivery Devices Total Addressable Market (TAM)

6. Drug And Gene Delivery Devices Market Segmentation

  • 6.1. Global Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Viral
  • Non-viral
  • 6.2. Global Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In Situ
  • Ex Vivo
  • 6.3. Global Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Inhalation
  • Transdermal
  • Injectable
  • Ocular
  • Nasal
  • Topical
  • 6.4. Global Drug And Gene Delivery Devices Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adenovirus Vectors
  • Lentivirus Vectors
  • Adeno-Associated Virus (AAV) Vectors
  • Herpes Simplex Virus (HSV) Vectors
  • Retrovirus Vectors
  • Baculovirus Vectors
  • Vaccinia Virus Vectors
  • Sendai Virus Vectors
  • 6.5. Global Drug And Gene Delivery Devices Market, Sub-Segmentation Of Non-Viral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lipid Nanoparticles (LNP)
  • Polymeric Nanoparticles
  • Liposomes
  • Dendrimers
  • Naked DNA/RNA Delivery
  • Electroporation-Based Delivery Systems
  • Nanoparticle-Based Delivery Systems
  • Polymer Micelles And Hydrogels

7. Drug And Gene Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Drug And Gene Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug And Gene Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug And Gene Delivery Devices Market

  • 8.1. Asia-Pacific Drug And Gene Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug And Gene Delivery Devices Market

  • 9.1. China Drug And Gene Delivery Devices Market Overview
  • 9.2. China Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug And Gene Delivery Devices Market

  • 10.1. India Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug And Gene Delivery Devices Market

  • 11.1. Japan Drug And Gene Delivery Devices Market Overview
  • 11.2. Japan Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug And Gene Delivery Devices Market

  • 12.1. Australia Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug And Gene Delivery Devices Market

  • 13.1. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug And Gene Delivery Devices Market

  • 14.1. South Korea Drug And Gene Delivery Devices Market Overview
  • 14.2. South Korea Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug And Gene Delivery Devices Market

  • 15.1. Western Europe Drug And Gene Delivery Devices Market Overview
  • 15.2. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug And Gene Delivery Devices Market

  • 16.1. UK Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug And Gene Delivery Devices Market

  • 17.1. Germany Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug And Gene Delivery Devices Market

  • 18.1. France Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug And Gene Delivery Devices Market

  • 19.1. Italy Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug And Gene Delivery Devices Market

  • 20.1. Spain Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug And Gene Delivery Devices Market

  • 21.1. Eastern Europe Drug And Gene Delivery Devices Market Overview
  • 21.2. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug And Gene Delivery Devices Market

  • 22.1. Russia Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug And Gene Delivery Devices Market

  • 23.1. North America Drug And Gene Delivery Devices Market Overview
  • 23.2. North America Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug And Gene Delivery Devices Market

  • 24.1. USA Drug And Gene Delivery Devices Market Overview
  • 24.2. USA Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug And Gene Delivery Devices Market

  • 25.1. Canada Drug And Gene Delivery Devices Market Overview
  • 25.2. Canada Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug And Gene Delivery Devices Market

  • 26.1. South America Drug And Gene Delivery Devices Market Overview
  • 26.2. South America Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug And Gene Delivery Devices Market

  • 27.1. Brazil Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug And Gene Delivery Devices Market

  • 28.1. Middle East Drug And Gene Delivery Devices Market Overview
  • 28.2. Middle East Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug And Gene Delivery Devices Market

  • 29.1. Africa Drug And Gene Delivery Devices Market Overview
  • 29.2. Africa Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug And Gene Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Drug And Gene Delivery Devices Market Competitive Landscape
  • 30.2. Drug And Gene Delivery Devices Market Company Profiles
    • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Drug And Gene Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Amgen Inc.
  • 31.2. Moderna Inc.
  • 31.3. Biogen Inc.
  • 31.4. Sarepta Therapeutics Inc.
  • 31.5. SCIEX
  • 31.6. Halozyme Therapeutics Inc.
  • 31.7. ViiV Healthcare Limited
  • 31.8. Uniqure NV
  • 31.9. Cytokinetics Inc.
  • 31.10. Prothena Corporation plc
  • 31.11. Intellia Therapeutics Inc.
  • 31.12. Voyager Therapeutics Inc.
  • 31.13. sfm medical devices GmbH
  • 31.14. Inovio Pharmaceuticals Inc.
  • 31.15. GenSight Biologics S.A.

32. Global Drug And Gene Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug And Gene Delivery Devices Market

34. Recent Developments In The Drug And Gene Delivery Devices Market

35. Drug And Gene Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Drug And Gene Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug And Gene Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug And Gene Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer